97 related articles for article (PubMed ID: 23897043)
1. Validation of a yeast functional assay for p53 mutations using clonal sequencing.
Iggo R; Rudewicz J; Monceau E; Sevenet N; Bergh J; Sjoblom T; Bonnefoi H
J Pathol; 2013 Dec; 231(4):441-8. PubMed ID: 23897043
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response.
Deissler H; Kafka A; Schuster E; Sauer G; Kreienberg R; Zeillinger R
Oncol Rep; 2004 Jun; 11(6):1281-6. PubMed ID: 15138567
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of transcript mutations due to transcriptional slippage in rat p53 tumor suppressor gene with the use of yeast functional assay].
Ba Y
Hokkaido Igaku Zasshi; 1999 May; 74(3):173-88. PubMed ID: 10422562
[TBL] [Abstract][Full Text] [Related]
4. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.
Duddy PM; Hanby AM; Barnes DM; Camplejohn RS
J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
6. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study.
Fouquet C; Antoine M; Tisserand P; Favis R; Wislez M; Commo F; Rabbe N; Carette MF; Milleron B; Barany F; Cadranel J; Zalcman G; Soussi T
Clin Cancer Res; 2004 May; 10(10):3479-89. PubMed ID: 15161705
[TBL] [Abstract][Full Text] [Related]
7. p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients.
Bonnefoi H; Ducraux A; Movarekhi S; Pelte MF; Bongard S; Lurati E; Iggo R
Br J Cancer; 2002 Mar; 86(5):750-5. PubMed ID: 11875738
[TBL] [Abstract][Full Text] [Related]
8. [Detectability and diagnostic criteria of p53 gene mutations in human oral squamous cell carcinoma using yeast functional assay].
Kashiwazaki H
Hokkaido Igaku Zasshi; 1997 Mar; 72(2):211-24. PubMed ID: 9145313
[TBL] [Abstract][Full Text] [Related]
9. Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.
Tada M; Iggo RD; Ishii N; Shinohe Y; Sakuma S; Estreicher A; Sawamura Y; Abe H
Int J Cancer; 1996 Jul; 67(3):447-50. PubMed ID: 8707423
[TBL] [Abstract][Full Text] [Related]
10. Significance of TP53 mutations determined by next-generation "deep" sequencing in prognosis of estrogen receptor-positive breast cancer.
Uji K; Naoi Y; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
Cancer Lett; 2014 Jan; 342(1):19-26. PubMed ID: 23973262
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of mouse p53 yeast functional assay and evaluation of its detectability of p53 gene mutation].
Tsunematsu I
Hokkaido Igaku Zasshi; 1999 Jul; 74(4):301-14. PubMed ID: 10480037
[TBL] [Abstract][Full Text] [Related]
12. [Analyses of p53 mutations in breast cancers with a combined use of yeast functional assay and immunohistochemical staining].
Takahashi M
Hokkaido Igaku Zasshi; 1998 May; 73(3):275-86. PubMed ID: 9719952
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of p53 mutation analysis in bladder cancer tissue and urine sediment by functional assay in yeast.
Schlichtholz B; Presler M; Matuszewski M
Carcinogenesis; 2004 Dec; 25(12):2319-23. PubMed ID: 15308588
[TBL] [Abstract][Full Text] [Related]
14. Detection of p53 mutations in Hong Kong colorectal carcinomas by conventional PCR-SSCP analysis versus p53 yeast functional assays.
Leung CS; Lung ML
Anticancer Res; 1999; 19(1A):625-8. PubMed ID: 10226610
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of yeast functional assay to detect p53 gene mutation in minute endoscopic samples of colonic mucosal neoplasia].
Nakamura Y
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):505-17. PubMed ID: 9846280
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
17. Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors.
Pfister C; Flaman JM; Martin C; Grise P; Frebourg T
J Urol; 1999 Jun; 161(6):1973-5. PubMed ID: 10332483
[TBL] [Abstract][Full Text] [Related]
18. ThinPrep-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosis: application to p53 mutation analysis.
Tisserand P; Fouquet C; Marck V; Mallard C; Fabre M; Vielh P; Soussi T
Cancer; 2003 Aug; 99(4):223-32. PubMed ID: 12925984
[TBL] [Abstract][Full Text] [Related]
19. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
